The Effects of Methylphenidate on the Quality of Life in Terminal Cancer Patients
スポンサーリンク
概要
- 論文の詳細を見る
Methylphenidate improved opioid-induced somnolence and neurobehavioral disorder in 4 terminal cancer patients. All the patients had suffered from cancer pain and morphine-induced drowsiness, which limited further use of morphine. Small doses of methylphenidate (1) counteracted the morphine-induced daytime drowsiness and night-time awakening, (2) brought good analgesia owing to further use of morphine and (3) treated neurobehavioral disorders in eating, conversation, and walking. No severe adverse effects requiring discontinuation of methylphenidate were observed in our experience. Methylphenidate is effective for opioid-induced daytime somnolence and improves the quality of life in terminal cancer patient.
- 一般社団法人 日本ペインクリニック学会の論文
一般社団法人 日本ペインクリニック学会 | 論文
- 神経障害性疼痛の症状から予測するガバペンチンの鎮痛効果
- 腰部硬膜外穿刺における各種画像検査による距離の予測
- くも膜下モルヒネに高用量のブピバカインを併用し良好な鎮痛が得られた2 症例
- 尖圭コンジローマ外科的切除時の痛み緩和目的でのリドカインテープ(ペンレス^【○!R】)使用経験
- 特発性脳脊髄液漏出症に対する経椎間孔的硬膜外自家血パッチの経験